<DOC>
	<DOCNO>NCT02221232</DOCNO>
	<brief_summary>The purpose pilot study evaluate antimicrobial property single test product , vehicle product reference product apply two different area use patient preoperative skin preparation .</brief_summary>
	<brief_title>Efficacy Study Evaluate Antimicrobial Effectiveness ZuraPrepâ„¢</brief_title>
	<detailed_description>This open label pilot study evaluate antimicrobial property single test product , vehicle product reference product apply bilaterally skin abdomen inguina . Testing perform accord FDA TFM Effectiveness Testing Patient Preoperative Skin Preparation .</detailed_description>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Subjects may either sex , least 18 year age race . Subjects must good general health , evidence Subject Confidential Information Acceptance Criteria Subjects must read sign Informed Consent Form , Authorization Use Disclose Protected Health Information Form , List Restricted Products Exposure test sit antimicrobial agent , medicate soap , medicate shampoo , medicate lotion , use biocidetreated pool hot tub , use tan bed , sunbathe 14day pretest conditioning period test period . Use topical systemic antimicrobial , antibiotic , steroid ( hormone contraception postmenopausal indication ) , product know affect normal microbial flora skin 14day pretest conditioning period test period . Exposure test sit strong detergent , solvent , irritant 14day pretest conditioning period test period . Known allergy vinyl , latex ( rubber ) , alcohols , metal , ink , tape adhesive , common antibacterial agent find soap , lotion , ointment , particularly chlorhexidine gluconate ( CHG ) , citric acid , methylene blue , methylparaben , propylparaben , isopropyl alcohol . A medical diagnosis physical condition , current recent severe illness , asthma , diabetes , hepatitis , organ transplant , mitral valve prolapse , congenital heart disease , internal prosthesis , immunocompromised condition AIDS ( HIV positive ) . Subjects must unable become pregnant , willing use acceptable method contraception prevent pregnancy , female childbearing potential . Inability become pregnant would include subject : Male Females unable become pregnant ( i.e. , postmenopausal least 1 year surgically sterile due hysterectomy , bilateral oophorectomy , uterine ablation , bilateral tubal ligation ) Females childbearing potential use acceptable method contraception , include one follow method use least 2 week prior Treatment Day Visit . Acceptable method contraception include one follow method : Systemic birth control ( type birth control least 3 month prior enter study continuation type birth control throughout study ) Double barrier method ( condom spermicide diaphragm spermicide ) IUD Vasectomized partner ; Abstinence sexual intercourse Any large tattoo , scar , active skin rash , break skin test site . Dermatoses , cut , lesion , skin disorder around test sit A currently active skin disease inflammatory skin condition ( e.g. , contact dermatitis ) , opinion Consulting Physician Principal Investigator , would compromise subject safety study integrity . Showering , bathing , swim within 72 hour period prior Baseline Day , first Test Day , throughout test period . Participation another clinical study past 30 day current participation another clinical study . Any medical condition use medication , opinion Medical Expert/Consulting Physician Principal Investigator , preclude participation . Unwillingness fulfill performance requirement study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>ZuraPrep</keyword>
	<keyword>Antimicrobial</keyword>
	<keyword>Bio-Science Laboratories</keyword>
	<keyword>Zurex Pharma</keyword>
	<keyword>Surgical/Patient preoperative skin preparation</keyword>
</DOC>